Efficacy and safety of CD19-specific CAR T cell-based therapy in B-cell acute lymphoblastic leukemia patients

Qi, YK; Zhao, MF; Hu, YX; Wang, Y; Li, P; Cao, J; Shi, M; Tan, JQ; Zhang, M; Xiao, X; Xia, JY; Ma, S; Qiao, JL; Yan, ZL; Li, HJ; Pan, B; Sang, W; Li, DP; Li, ZY; Zhou, JF; Huang, H; Liang, AB; Zheng, JN; Xu, KL

Xu, KL (通讯作者),Xuzhou Med Univ, Dept Hematol, Affiliated Hosp, 99 West Huaihai Rd, Xuzhou 221002, Jiangsu, Peoples R China.

BLOOD, 2022; 139 (23): 3376

Abstract

Few studies have described chimeric antigen receptor (CAR) T-cell therapy for patients with B-cell acute lymphoblastic leukemia (B-ALL) with central n......

Full Text Link